Home › NDC Lookup › RxCUI directory › RxCUI 1297381

Hydrofluoric acid 0.01 MG/MG / phosphoric acid 0.0112 MG/MG / sodium fluoride 0.018 MG/MG... — RxCUI 1297381

RxNorm drug concept · Semantic clinical drug
RxCUI 1297381 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1297381
Official nameHydrofluoric acid 0.01 MG/MG / phosphoric acid 0.0112 MG/MG / sodium fluoride 0.018 MG/MG Oral Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrofluoric acid 1 % / phosphoric acid 1.12 % / sodium fluoride 1.8 % Oral Gel
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Hydrofluoric acid 0.01 MG/MG / phosphoric acid 0... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrofluoric acid 0.01 MG/MG / phosphoric acid 0.0112 MG/MG / sodium fluoride 0.018 MG/MG Oral Gel RxCUI 1297381

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrofluoric acid 5496
    • Phosphoric acid 8259
    • Sodium fluoride 9873
    • Hydrofluoric acid / phosphoric acid / sodium fluoride 692830
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrofluoric acid / phosphoric acid / sodium fluoride Oral Gel 826661
    • Hydrofluoric acid / phosphoric acid / sodium fluoride Oral Gel Product 1295600
    • Hydrofluoric acid / phosphoric acid / sodium fluoride Oral Product 1164024
    • Oral Gel 346169
    • Oral Gel Product 1294722
    • Oral Product 1151131
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydrofluoric acid 0.01 MG/MG 630051
    • Phosphoric acid 0.0112 MG/MG 1297379
    • Sodium fluoride 0.018 MG/MG 1297380

Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrofluoric acid 0.01 MG/MG SCDC · 630051
  • Phosphoric acid 0.0112 MG/MG SCDC · 1297379
  • Sodium fluoride 0.018 MG/MG SCDC · 1297380
  • Hydrofluoric acid / phosphoric acid / sodium fluoride Oral Gel SCDF · 826661
  • Hydrofluoric acid / phosphoric acid / sodium fluoride Oral Gel Product SCDG · 1295600
  • Hydrofluoric acid / phosphoric acid / sodium fluoride Oral Product SCDG · 1164024

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1297381 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55346-0942-01 497 g in 1 BOTTLE (55346-0942-1) Alpha-Pro Dental Technologies, Inc. 2013-04-01
55346-0943-01 497 g in 1 BOTTLE (55346-0943-1) Alpha-Pro Dental Technologies, Inc. 2013-04-01
Observed labelers: Dental Technologies, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.